Biofrontera

Woburn, United States

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

$8.5M raised

Jun 2025

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biofrontera raised?

Biofrontera has raised $8.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.

Who are Biofrontera's investors?

Biofrontera's investors include Rosalind Capital Partners, AIGH Capital Management.

Where is Biofrontera headquartered?

Biofrontera is headquartered in Woburn, United States.

What does Biofrontera do?

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

What stage is Biofrontera at?

Biofrontera is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 30, 2025.

MLA

"Biofrontera — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/biofrontera. Accessed July 2, 2026.

APA

VCBacked. (2025). Biofrontera — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biofrontera

Wikipedia (cite web)

{{cite web |title=Biofrontera — Funding & Investors |url=https://www.vcbacked.co/company/biofrontera |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 30, 2025.